Study of sertraline in the prevention of depression in stroke patients

Completed

Phase N/A Results

Summary of Purpose

To evaluate the efficacy of sertraline in preventing post-stroke depression.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 June 2003.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Pfizer A/S, Gert Jorgensen legat, and the Brain Cause.

Trial Design

Randomized, double-blind, placebo controlled study.

Contacts

Not available